FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/28/2026
ATARA Biotherapeutics (NASDAQ: ATRA) reported Q1 EPS of ($1.20), $0.21 better than the analyst estimate of ($1.41).
Atara believes that its cash, cash equivalents and short-term investments as of March 31, 2020, are sufficient to fund planned operations into the second quarter of 2021.
Cash, cash equivalents and short-term... More
